Point72 Middle East FZE - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 145 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Middle East FZE ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2023$424,784
+17.5%
24,218
-5.7%
0.01%
+30.0%
Q2 2023$361,42025,6690.01%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 30,000$560,1000.52%
ADIRONDACK TRUST CO 875$16,2660.01%
CWM, LLC 451$80.00%
BARCLAYS PLC 34,839$6500.00%
OSAIC HOLDINGS, INC. 623$11,6310.00%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders